News

Northwest Bio crashes on funding fears

20 August 2008 09:21:00

Northwest Biotherapeutics has less than six weeks to raise extra cash to keep the day to day business in tact despite just agreeing a $1m loan from Toucan Partners.

The biotech outfit watched its shares crumble as investors panicked at the firm's admission it had just $1.1m of cash on hand, including the loan.

"The company estimates that its available cash is sufficient to support its day to day operations through to the end of September 2008," it said.

"It therefore needs to raise significant additional capital to fund its clinical trials and other operating activities and to repay indebtedness."

Northwest is in "late stage discussions with several parties" to try and get the additional funds by the end of the year, but warned shareholders that its failure to do so "will have a material adverse effect on the company financial position and operations".

The group, focused on developing immunotherapy products that treat cancers, narrowed its net loss for the second quarter period ended 30 June to $6.05m from $7.96m a year ago. Interest expenses closed to $69,000 from $4.73m in 2007, but operating expenses rose to $6m from $3.91m.

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.